Long COVID Between People With and Without HIV: A Statewide Cohort Analysis
Authors:
- 1 June 2026
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 101 (6) , 604-611
Abstract
Background: This study aimed to compare the risks of a panel of long COVID (LC) manifestations between people with HIV (PWH) and people without HIV (PWoH). Methods: Using integrated statewide electronic health record data from the HIV cohort and COVID-19 tester cohort, we identified COVID-19–positive individuals by HIV status between March 02, 2020, and January 15, 2022, in South Carolina. A total of 13 diagnosis groups encompassing 131 potential LC categories were identified. We used inverse probability weighting based on propensity scores to balance covariates between the PWH and PWoH, including age, sex, race, and vaccination status. Cox Proportional Hazard regression models were used to estimate the risk of each diagnosis group examined. Results: Among a total of 838,520 COVID-19–positive individuals, 2662 were with HIV and 835,858 were without HIV. The prevalence of any LC diagnosis was 16.3% and 10.6% for PWH and PWoH, respectively. Compared with PWoH, PWH were found to be at a higher risk of at least one of the LC diagnosis groups (hazard ratio [HR] = 1.29, 95% confidence interval [95% CI]: 1.09 to 1.54) and the highest risk was for diseases of the nervous system (HR = 2.04, 95% CI: 1.42 to 2.92), followed by mental disorders (HR = 1.78, 95% CI: 1.12 to 2.82) and respiratory system (HR = 1.78, 95% CI: 1.18 to 2.69). Conclusions: Our study highlights the consistent and elevated LC burden in PWH, emphasizing the importance of sustained follow-up for COVID-19 survivors to improve their clinical outcomes and prevent morbidity of LC.Keywords
Funding Information
- National Institutes of Health (R21AI170159-01A1)
This publication has 28 references indexed in Scilit:
- Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort studyeClinicalMedicine, 2024
- Vaccination and the risk of post-acute sequelae after COVID-19 in the Omicron-predominant periodClinical Microbiology and Infection, 2024
- Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKeClinicalMedicine, 2023
- HIV and inflammatory markers are associated with persistent COVID‐19 symptomsImmunity, Inflammation and Disease, 2023
- The impact of the COVID‐19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping reviewJournal of the International AIDS Society, 2023
- Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER ProgramJournal of General Internal Medicine, 2023
- Prevalence and Correlates of Long COVID Symptoms Among US AdultsJAMA Network Open, 2022
- Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2JAMA Network Open, 2022
- Long COVID: current definitionInfection, 2021
- The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studiesStatistics in Medicine, 2010